391 related articles for article (PubMed ID: 25731642)
21. Sclerotherapy complications of peripheral venous malformations.
Aronniemi J; Castrén E; Lappalainen K; Vuola P; Salminen P; Pitkäranta A; Pekkola J
Phlebology; 2016 Dec; 31(10):712-722. PubMed ID: 26494223
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol).
Siniluoto TM; Svendsen PA; Wikholm GM; Fogdestam I; Edström S
Scand J Plast Reconstr Surg Hand Surg; 1997 Jun; 31(2):145-50. PubMed ID: 9232699
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
Kumar S; Bhavana K; Kumar S; Kumar P
J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of foam sclerotherapy with sodium tetradecyl sulfate as preferred sclerosant of venous malformations based on experience from a single specialist center.
Arasakumar DRB; Pang C; Evans N; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J; Lim CS
J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):379-388. PubMed ID: 36328136
[TBL] [Abstract][Full Text] [Related]
25. Venous Malformations of the Head and Neck.
Seront E; Vikkula M; Boon LM
Otolaryngol Clin North Am; 2018 Feb; 51(1):173-184. PubMed ID: 29217061
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.
Mimura H; Kanazawa S; Yasui K; Fujiwara H; Hyodo T; Mukai T; Dendo S; Iguchi T; Hiraki T; Koshima I; Hiraki Y
Acta Med Okayama; 2003 Oct; 57(5):227-34. PubMed ID: 14679400
[TBL] [Abstract][Full Text] [Related]
27. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
28. Venous malformations of the head and neck: current concepts in management.
Fowell C; Verea Linares C; Jones R; Nishikawa H; Monaghan A
Br J Oral Maxillofac Surg; 2017 Jan; 55(1):3-9. PubMed ID: 27894790
[TBL] [Abstract][Full Text] [Related]
29. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Frullini A; Cavezzi A
Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
[TBL] [Abstract][Full Text] [Related]
30. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
[TBL] [Abstract][Full Text] [Related]
31. Sclerotherapy of craniofacial venous malformations: complications and results.
Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
[TBL] [Abstract][Full Text] [Related]
32. Patient satisfaction after sclerotherapy of venous malformations in children.
Nakahata K; Uehara S; Zenitani M; Nakamura M; Osuga K; Okuyama H
Pediatr Int; 2016 Aug; 58(8):721-5. PubMed ID: 26662951
[TBL] [Abstract][Full Text] [Related]
33. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.
Stuart S; Barnacle AM; Smith G; Pitt M; Roebuck DJ
Radiology; 2015 Mar; 274(3):897-905. PubMed ID: 25271855
[TBL] [Abstract][Full Text] [Related]
34. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
35. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance.
Wang YA; Zheng JW; Zhu HG; Ye WM; He Y; Zhang ZY
Phlebology; 2010 Jun; 25(3):138-44. PubMed ID: 20483863
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.
Cahill AM; Nijs E; Ballah D; Rabinowitz D; Thompson L; Rintoul N; Hedrick H; Jacobs I; Low D
J Pediatr Surg; 2011 Nov; 46(11):2083-95. PubMed ID: 22075337
[TBL] [Abstract][Full Text] [Related]
37. Sclerotherapy for venous malformations of the glans penis.
Marrocco-Trischitta MM; Nicodemi EM; Stillo F
Urology; 2001 Feb; 57(2):310-3. PubMed ID: 11182343
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
40. MRI-guided percutaneous sclerotherapy of venous malformations: initial clinical experience using a 3T MRI system.
O'Mara DM; Berges AJ; Fritz J; Weiss CR
Clin Imaging; 2020 Sep; 65():8-14. PubMed ID: 32353719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
